Acute dystonia after initial doses of ziprasidone: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 745-747

  Yumru, Mehmet ^a   Savas, Haluk A ^a   Selek, Salih ^a   Savas, Esen ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Av Cengiz Gokcek State Hospital   (Turkey)

Author keywords

Acute dystonia; Atypical antipsychotics; Ziprasidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; FLUOXETINE; ZIPRASIDONE;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; OBSESSIVE COMPULSIVE DISORDER; SYMPTOM; TORTICOLLIS; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DYSTONIA; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PIPERAZINES; THIAZOLES;

EID: 33646118224     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.01.024     Document Type: Article

References (21)

1. Alevizos B., Papageorgiou C., and Christodoulou G.N. Acute dystonia caused by low dosage of olanzapine. J Neuropsychiatry Clin Neurosci 15 (2003) 241
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), APA, Washington, DC
3. Schmidt A.W., Lebel L.A., Harry R., Howard Jr., and Zorn S.H. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425 (2001) 197-201
4. Brody A.L. Acute dystonia induced by rapid increase in risperidone dosage. J Clin Psychopharmacol 16 (1996) 461-462
5. Casey D.E. Neuroleptic-induced acute dystonia. In: Lang A.E., and Weiner W.J. (Eds). Drug-induced movement disorders (1992), Futura, Mount Kisco, NY 21-40
6. Casey D.E. Neuroleptic-induced acute dystonia. In: Widiger T.A., Frances A.J., Pincus H.A., First M.B., Ross R., and Davis W. (Eds). DSM-IV Source Book vol. 1 (1994), American Psychiatric Association, Washington 545-559
7. Coplan J.D., Tiffon L., and Gorman J.M. Therapeutic strategies for the patient with treatment-resistant anxiety. J Clin Psychiatry 54 (1993) 69-74
8. Crane D.L. Ziprasidone as an augmenting agent in the treatment of anxiety-spectrum disorders. CNS Spectr 10 (2005) 176-179
9. Dew R.E., and Hughes D. Acute dystonic reaction with moderate-dose ziprasidone. J Clin Psychopharmacol 24 (2004) 563-564
10. Dominguez-Moran J.A., Callejo J.M., Fernandez-Ruiz L.C., and Martinez-Castrillo J.C. Acute paroxysmal dystonia induced by fluoxetine. Mov Disord 16 (2001) 767-769
11. Etxebeste M., Aragues E., Malo P., and Pacheco L. Olanzapine and panic attacks. Am J Psychiatry 157 (2000) 659-660
12. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale brown obsessive compulsive scale: I. Development, use and reliability. Arch Gen Psychiatry 46 (1989) 1006
13. Hollander E., Beinstock C.A., Koran L.M., Pallanti S., Marazziti D., Rasmussen S.A., et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry 63 (2002) 20-29
14. Kaplan H.I., and Sadock B.J. Comprehensive textbook of psychiatry. 6th ed. (1995), Williams & Wilkins, Baltimore 2003-2004
15. Kropp S., Hauser U., and Ziegenbein M. Quetiapine-associated acute dystonia. Ann Pharmacother 38 (2004) 719-720
16. Marazziti D., and Pallanti S. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder. Am J Psychiatry 156 (1999) 1834-1835
17. Marusic A., and Farmer A. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder. Br J Psychiatry 177 (2000) 567
18. Mason M.N., Johnson C.E., and Piasecki M. Ziprasidone-induced acute dystonia. Am J Psychiatry 162 (2005) 625-626
19. Ramos A.E., Shytle R.D., Silver A.A., and Sanberg P.R. Ziprasidone-induced oculogyric crisis. J Am Acad Child Adolesc Psych 42 (2003) 1013-1014
20. van Harten P.N., Hoek H.W., and Kahn R.S. Acute dystonia induced by drug treatment. BMJ 319 (1999) 623-626
21. Weiden Peter J., Naveed I., Mendelowitz A.J., Rajiv T., Zimbroff D.L., and Ruth R. Best clinical practice with ziprasidone: update after one year of experience. J Psychiatr Pract 8 (2002) 81-97